286 related articles for article (PubMed ID: 22043308)
1. RNA-Seq analyses generate comprehensive transcriptomic landscape and reveal complex transcript patterns in hepatocellular carcinoma.
Huang Q; Lin B; Liu H; Ma X; Mo F; Yu W; Li L; Li H; Tian T; Wu D; Shen F; Xing J; Chen ZN
PLoS One; 2011; 6(10):e26168. PubMed ID: 22043308
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of pathogenesis in hepatocellular carcinoma revealed by RNA‑sequencing.
Liu Y; Yang Z; Du F; Yang Q; Hou J; Yan X; Geng Y; Zhao Y; Wang H
Mol Med Rep; 2017 Nov; 16(5):6674-6682. PubMed ID: 28901494
[TBL] [Abstract][Full Text] [Related]
3. Identification and functional analysis of differentially expressed genes in poorly differentiated hepatocellular carcinoma using RNA-seq.
Huang Y; Pan J; Chen D; Zheng J; Qiu F; Li F; Wu Y; Wu W; Huang X; Qian J
Oncotarget; 2017 May; 8(22):35973-35983. PubMed ID: 28415592
[TBL] [Abstract][Full Text] [Related]
4. RNA-Seq profiling reveals novel hepatic gene expression pattern in aflatoxin B1 treated rats.
Merrick BA; Phadke DP; Auerbach SS; Mav D; Stiegelmeyer SM; Shah RR; Tice RR
PLoS One; 2013; 8(4):e61768. PubMed ID: 23630614
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of biological networks and the eukaryotic initiation factor 4A-3 gene as pivotal in hepatocellular carcinoma.
Lin Y; Liang R; Mao Y; Ye J; Mai R; Gao X; Liu Z; Wainwright T; Li Q; Luo M; Ge L; Li Y; Zou D
J Cell Biochem; 2020 Oct; 121(10):4094-4107. PubMed ID: 31898336
[TBL] [Abstract][Full Text] [Related]
6. Accurate transcriptome assembly by Nanopore RNA sequencing reveals novel functional transcripts in hepatocellular carcinoma.
Fang Y; Chen G; Chen F; Hu E; Dong X; Li Z; He L; Sun Y; Qiu L; Xu H; Cai Z; Liu X
Cancer Sci; 2021 Sep; 112(9):3555-3568. PubMed ID: 34255396
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of transcriptome profiles in hepatocellular carcinoma.
Jin Y; Lee WY; Toh ST; Tennakoon C; Toh HC; Chow PK; Chung AY; Chong SS; Ooi LL; Sung WK; Lee CG
J Transl Med; 2019 Aug; 17(1):273. PubMed ID: 31429776
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel long non-coding RNAs deregulated in hepatocellular carcinoma using RNA-sequencing.
Esposti DD; Hernandez-Vargas H; Voegele C; Fernandez-Jimenez N; Forey N; Bancel B; Le Calvez-Kelm F; McKay J; Merle P; Herceg Z
Oncotarget; 2016 May; 7(22):31862-77. PubMed ID: 26887054
[TBL] [Abstract][Full Text] [Related]
9. Identification of the Pathogenic Biomarkers for Hepatocellular Carcinoma Based on RNA-seq Analyses.
Jiang W; Zhang L; Guo Q; Wang H; Ma M; Sun J; Chen C
Pathol Oncol Res; 2019 Jul; 25(3):1207-1213. PubMed ID: 30680535
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics identification of crucial genes and pathways associated with hepatocellular carcinoma.
Gao X; Wang X; Zhang S
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30341252
[TBL] [Abstract][Full Text] [Related]
11. Long-Read RNA Sequencing Identifies Alternative Splice Variants in Hepatocellular Carcinoma and Tumor-Specific Isoforms.
Chen H; Gao F; He M; Ding XF; Wong AM; Sze SC; Yu AC; Sun T; Chan AW; Wang X; Wong N
Hepatology; 2019 Sep; 70(3):1011-1025. PubMed ID: 30637779
[TBL] [Abstract][Full Text] [Related]
12. Global profiling of alternative RNA splicing events provides insights into molecular differences between various types of hepatocellular carcinoma.
Tremblay MP; Armero VE; Allaire A; Boudreault S; Martenon-Brodeur C; Durand M; Lapointe E; Thibault P; Tremblay-Létourneau M; Perreault JP; Scott MS; Bisaillon M
BMC Genomics; 2016 Aug; 17(1):683. PubMed ID: 27565572
[TBL] [Abstract][Full Text] [Related]
13. Identification of important long non-coding RNAs and highly recurrent aberrant alternative splicing events in hepatocellular carcinoma through integrative analysis of multiple RNA-Seq datasets.
Zhang L; Liu X; Zhang X; Chen R
Mol Genet Genomics; 2016 Jun; 291(3):1035-51. PubMed ID: 26711644
[TBL] [Abstract][Full Text] [Related]
14. Differential alternative splicing regulation among hepatocellular carcinoma with different risk factors.
Jin YJ; Byun S; Han S; Chamberlin J; Kim D; Kim MJ; Lee Y
BMC Med Genomics; 2019 Dec; 12(Suppl 8):175. PubMed ID: 31856847
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of alternative splicing isoforms as novel biomarker candidates in hepatocellular carcinoma.
Wu P; Zhou D; Wang Y; Lin W; Sun A; Wei H; Fang Y; Cong X; Jiang Y
Oncol Rep; 2019 Mar; 41(3):1929-1937. PubMed ID: 30592283
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of sexual dimorphism‑linked gene expression profile in hepatocellular carcinoma.
Wu Y; Yao N; Feng Y; Tian Z; Yang Y; Zhao Y
Oncol Rep; 2019 Sep; 42(3):937-952. PubMed ID: 31322260
[TBL] [Abstract][Full Text] [Related]
17. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
[No Abstract] [Full Text] [Related]
18. RNA sequencing analysis of hepatocellular carcinoma identified oxidative phosphorylation as a major pathologic feature.
Liu Y; Al-Adra DP; Lan R; Jung G; Li H; Yeh MM; Liu YZ
Hepatol Commun; 2022 Aug; 6(8):2170-2181. PubMed ID: 35344307
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
[TBL] [Abstract][Full Text] [Related]
20. Transcriptome-Wide Analysis Reveals the Landscape of Aberrant Alternative Splicing Events in Liver Cancer.
Li S; Hu Z; Zhao Y; Huang S; He X
Hepatology; 2019 Jan; 69(1):359-375. PubMed ID: 30014619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
